FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

IRS confirms Trump-ordered $1,776 ‘Warrior Dividend’ for 1.45M troops is tax-free

Michael Cohen says NY prosecutors ‘pressured and coerced’ him into anti-Trump testimony

Illegal alien with 24 convictions among ‘worst of the worst’ arrested in Minnesota ICE operation: DHS

CNN Forced to Admit Trump’s Efforts Have Already Had a ‘Huge’ Impact on Housing Affordability

Mother of Hunter Biden’s Youngest Daughter Asks Judge to Jail Him for ‘Ghosting’ Girl

Elderly Man Sues McDonald’s, Says Staff Failed to Act Before Wife Was Killed by Vagrant in Unprovoked Drive-Thru Attack

Schumer reveals ‘bipartisan’ plans to reverse DOGE cuts as lawmakers work through funding push

Cat caught on camera starting dangerous kitchen fire after jumping on stove and turning on burner

Mamdani announces $2.1M settlement with major landlord as tenants describe ‘nightmare’ conditions

Utah County accuses Tyler Robinson legal team of ‘ambush’ effort to disqualify prosecutors

Tyler Robinson Seeks to Upend Case by Getting Prosecutors Disqualified

Teen Barely Survives 260-Foot Fall While Hiking, Thanks to His High-Tech Headphones

Trump Administration Says Banks Will Soon Begin Distributing ‘Trump Cards’

DOJ urges judge to reject lawmakers’ bid for special master in Epstein files dispute

Cancer-stricken children urge Bernie Sanders to back life-saving pediatric healthcare bill

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”